| Literature DB >> 31686916 |
Thu-Thi Pham1, Minji Hwang2, Eun-Sook Lee1,3,4, Sun-Young Kong1,3,4, So-Youn Jung3,4, Seeyoun Lee4, Jeongseon Kim1,3, Mina Ha5, Sun-Young Kim1, Boyoung Park2.
Abstract
PURPOSE: This study evaluated the association between night-shift work (NSW) and breast cancer risk as well as subtypes of breast cancer in Korean women. PATIENTS AND METHODS: The study population included 1721 female breast cancer cases and 1721 female controls matched by age. The subtypes of breast cancer were determined based on estrogen, progesterone, and human epidermal growth factor receptor 2 statuses by reviewing pathology reports. Odds ratios (ORs) for NSW experience, age at commencement of NSW, frequency, and duration were estimated using conditional logistic regression and were adjusted for confounders such as parity and socioeconomic status-related factors.Entities:
Keywords: breast cancer; estrogen receptor; hormone receptor; human epidermal growth factor receptor 2 ; night-shift work; progesterone receptor
Year: 2019 PMID: 31686916 PMCID: PMC6709512 DOI: 10.2147/CLEP.S199521
Source DB: PubMed Journal: Clin Epidemiol ISSN: 1179-1349 Impact factor: 4.790
Figure 1The odds ratios (ORs) showed the association between all the selected factors and night-shift work as well as breast cancer. 1Never pregnancy as reference, 2high school and under as the reference, 318.5≤ BMI<25 as reference, 4aged 14 and under as reference, 5never smoking tobacco as reference, 6never use of female hormone treatment in menopausal women as reference, 7not having family history of breast cancer in first-degree relatives as reference.
Abbreviations: yrs, years; BMI, body mass index (kg/m2); FHT, female hormone treatment; MW, menopausal women.
Distribution of baseline characteristics in age-matched breast cancer patients and controls
| Characteristics | Controls (N=1721) | Cases (N=1721) | ||
|---|---|---|---|---|
| N | N | % | N | % |
| Age group (years) | ||||
| <30 | 38 | 2.3 | 38 | 2.3 |
| 30–39 | 205 | 11.9 | 205 | 11.9 |
| 40–49 | 752 | 43.7 | 752 | 43.7 |
| 50–59 | 530 | 30.8 | 530 | 30.8 |
| 60–69 | 174 | 10.1 | 174 | 10.1 |
| ≥70 | 22 | 1.3 | 22 | 1.3 |
| Number of pregnanciesa | ||||
| Nullipara | 208 | 12.2 | 187 | 11.2 |
| 1–2 | 586 | 34.4 | 564 | 33.9 |
| ≥3 | 909 | 53.4 | 912 | 54.8 |
| Age at birth of first child (years)b | ||||
| Nullipara | 208 | 12.5 | 187 | 11.7 |
| <28 | 867 | 52.2 | 919 | 57.5 |
| ≥28 | 586 | 35.3 | 492 | 30.8 |
| Educationc | ||||
| <High school | 722 | 48.9 | 704 | 46.4 |
| ≥University | 756 | 51.2 | 813 | 53.6 |
| BMI (kg/m2)d | ||||
| <18.5 | 1181 | 70.3 | 1279 | 75.5 |
| ≥18.5–24.9 | 73 | 4.3 | 110 | 6.5 |
| ≥25 | 426 | 25.4 | 304 | 18.0 |
| Age at menarche (years)e | ||||
| ≤14 | 1213 | 71.1 | 1090 | 63.9 |
| >14 | 493 | 28.9 | 616 | 36.1 |
| Tobacco smokingf | ||||
| Never | 1521 | 88.6 | 1544 | 90.6 |
| Ever | 195 | 11.4 | 161 | 9.4 |
| Use of female hormone treatment in menopausal womeng | ||||
| Never | 455 | 73.4 | 530 | 78.9 |
| Ever | 165 | 26.6 | 142 | 21.1 |
| Family history of breast cancer in first-degree relativesh | ||||
| No | 1434 | 84.7 | 1290 | 76.3 |
| Yes | 260 | 15.3 | 400 | 23.7 |
Notes: a18 cases and 58 controls with missing information; b60 cases and 123 controls with missing information; c204 cases and 243 controls with missing information; d41 cases and 28 controls with missing information; e15 cases and 15 controls with missing information; f5 cases and 16 controls with missing information; gestimated in 721 postmenopausal cases and 645 postmenopausal controls, 49 cases and 25 controls with missing information; h31 cases and 27 controls with missing information.
Abbreviations: N, number; BMI, body mass index (kg/m2).
Distribution of night-shift work characteristics and associations with breast cancer in age-matched breast cancer patients and controls
| Characteristics | Controls | Cases | aAdjusted OR (95%CI) | bAdjusted OR (95%CI) | ||
|---|---|---|---|---|---|---|
| (N=1721) | (N=1721) | |||||
| N | % | N | % | |||
| Night-shift work status | ||||||
| Had job but no NSW | 1556 | 90.4 | 1539 | 89.4 | ref | ref |
| Ever | 165 | 9.6 | 182 | 10.6 | 1.11 (0.89–1.40) | 1.10 (0.88–1.39) |
| Age at starting working night shifts (years)c | ||||||
| ≤30 | 86 | 5.0 | 96 | 5.6 | 1.11 (0.82–1.51) | 1.08 (0.8–1.49) |
| >30 | 72 | 4.2 | 82 | 4.8 | 1.16 (0.84–1.62) | 1.16 (0.83–1.63) |
| Number of days per weekd | ||||||
| 1–5 days | 77 | 4.5 | 88 | 5.2 | 1.17 (0.85–1.60) | 1.13 (0.82–1.57) |
| >5 days | 66 | 3.9 | 78 | 4.6 | 1.17 (0.84–1.65) | 1.16 (0.83–1.66) |
| Time starting NSW (clock time)e | ||||||
| Before midnight | 137 | 8.0 | 163 | 9.5 | 1.20 (0.94–1.52) | 1.17 (0.93–1.51) |
| Midnight and after | 7 | 0.4 | 7 | 0.4 | 0.98 (0.34–2.80) | 0.85 (0.30–2.49) |
| Lifetime duration of night work (years)f | ||||||
| ≤10 | 139 | 8.1 | 145 | 8.4 | 1.07 (0.83–1.36) | 1.05 (0.83–1.36) |
| >10 | 21 | 1.2 | 35 | 2.0 | 1.55 (0.89–2.69) | 1.44 (0.82–2.55) |
| Lifetime cumulative frequency of night work (hrs)f | ||||||
| ≤10,000 | 86 | 5.0 | 94 | 5.5 | 1.11 (0.82–1.50) | 1.08 (0.80–1.49) |
| >10,000 – ≤35,000 | 59 | 3.7 | 63 | 3.9 | 1.09 (0.76–1.57) | 1.09 (0.76–1.59) |
| >35,000 | 15 | 0.6 | 23 | 1.1 | 1.42 (0.73–2.74) | 1.30 (0.66–2.58) |
Notes: 95% CI estimated using conditional logistic regression models; aadjusted for age, educational level, number of pregnancies, and age at birth of first child; badjusted for age, educational level, number of pregnancies, age at birth of first child, body mass index, age at menarche, alcohol consumption, smoking, use of female hormone treatment, and family history of breast cancer in first degree relatives; c4 cases and 7 controls with missing information; d16 cases and 22 controls with missing information; e12 cases and 21 controls with missing information; f2 cases and 5 controls with missing information.
Abbreviation: N, number.
Figure 2Adjusted OR (minimal adjustment) and 95% CI in 4 molecular subtypes of breast cancer (x axis) for odds ratios for breast cancer (y axis). The rounded points and CIs represent the estimated risks from each NSW exposure level in the study. While luminal A (ER- and/or PR-positive and HER2-negative), luminal B (ER- and/or PR-positive and HER2-positive), HER2-enriched (ER- and PR-negative and HER2-positive), and Triple-negative (all receptors negative), and OR and 95%CI from the multivariate logistic regression models.